S-Bank Fund Management’s DexCom DXCM Stock Holding History

S-Bank Fund Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,507	Closed	-$239K	–	216
2025 Q1	$239K	Buy	+3,507	New	+$286K	0.05%	152

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

S-Bank Fund Management's DXCM Position: Q2 2025 in Review

S-Bank Fund Management sold out of DexCom (DXCM) in Q2 2025, closing a stake of 3,507 shares — an estimated $239K sold.

S-Bank Fund Management first reported a position in DXCM in Q1 2025 and held it in 1 quarter. The position peaked at $239K in Q1 2025. 939 funds tracked by Wall St. Rank hold DXCM as of Q2 2025.

S-Bank Fund Management reported no remaining DexCom position as of Q2 2025 after selling out during the quarter.
S-Bank Fund Management sold 3,507 DexCom shares in Q2 2025, an estimated $239K.
S-Bank Fund Management first reported a position in DexCom in Q1 2025 and held it in 1 quarter.
S-Bank Fund Management's DexCom position peaked at $239K in Q1 2025.
939 funds tracked by Wall St. Rank held DexCom as of Q2 2025.

Based on S-Bank Fund Management's 13F filing for Q2 2025, filed 29 Jul 2025.